Tag Archives: severity

Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023 | MMWR – CDC

  1. Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023 | MMWR CDC
  2. Rise in RSV hospitalizations in young children across Canada CityNews
  3. ‘It’s a death sentence’: Bradford senior irked by cost of vaccine BayToday.ca
  4. Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023 | MMWR CDC
  5. RSV vaccine cost significant barrier to older Canadians, experts say Global News
  6. View Full Coverage on Google News

Read original article here

SARS-CoV-2 hijacks body’s metabolism to amplify COVID-19 severity – News-Medical.Net

  1. SARS-CoV-2 hijacks body’s metabolism to amplify COVID-19 severity News-Medical.Net
  2. A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon Nature.com
  3. Is discontinuing universal SARS-CoV-2 testing at hospital admission in England and Scotland associated with increased hospital-onset infections? News-Medical.Net
  4. Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants Nature.com
  5. Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy Nature.com
  6. View Full Coverage on Google News

Read original article here

Vulnerability with 9.8 severity in Control Web Panel is under active exploit

Getty Images

Malicious hackers have begun exploiting a critical vulnerability in unpatched versions of the Control Web Panel, a widely used interface for web hosting.

“This is an unauthenticated RCE,” members of the Shadowserver group wrote on Twitter, using the abbreviation for remote code exploit. “Exploitation is trivial and a PoC published.” PoC refers to a proof-of-concept code that exploits the vulnerability.

The vulnerability is tracked as CVE-2022-44877. It was discovered by Numan Türle of Gais Cyber Security and patched in October in version 0.9.8.1147. Advisories didn’t go public until earlier this month, however, making it likely some users still aren’t aware of the threat.

Figures provided by Security firm GreyNoise show that attacks began on January 7 and have slowly ticked up since then, with the most recent round continuing through Wednesday. The company said the exploits are coming from four separate IP addresses located in the US, Netherlands, and Thailand.

Shadowserver shows that there are roughly 38,000 IP addresses running Control Web Panel, with the highest concentration in Europe, followed by North America, and Asia.

The severity rating for CVE-2022-44877 is 9.8 out of a possible 10. “Bash commands can be run because double quotes are used to log incorrect entries to the system,” the advisory for the vulnerability stated. As a result, unauthenticated hackers can execute malicious commands during the login process. The following video demonstrates the flow of the exploit.

Centos Web Panel 7 Unauthenticated Remote Code Execution – CVE-2022-44877

The vulnerability resides in the /login/index.php component and resulted from CWP using a faulty structure when logging incorrect entries, according to the Daily Swig. The structure is: echo "incorrect entry, IP address, HTTP_REQUEST_URI" >> /blabla/wrong.log. “Since the request URI comes from the user, and as you can see it is within double quotes, it is possible to run commands such as $(blabla), which is a bash feature,” Türle told the publication.

Given the ease and severity of exploitation and the availability of working exploit code, organizations using Control Web Panel should ensure they’re running version 0.9.8.1147 or higher.

Read original article here

Study explores incidence, severity, and long COVID associations of SARS-CoV-2 reinfections

In a recent study posted to the medRxiv* preprint server, a team of researchers from the United States used electronic health records to characterize the incidence, biomarkers, attributes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections and evaluated the association between reinfections and long coronavirus disease (COVID).

Study: SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study. Image Credit: Ralf Liebhold/Shutterstock

Background

The emergent SARS-CoV-2 variants are increasing the incidence of breakthrough infections. Mutations in spike protein regions of these variants that increase immune escape, combined with the waning of the immunity induced by coronavirus disease 2019 (COVID-19) vaccines and previous SARS-CoV-2 infections are resulting in a rise in reinfections. Studies based on whole genome sequences of the SARS-CoV-2 variants isolated from reinfected patients have revealed that the variants responsible for reinfections are distinct from those that caused the earlier infections. However, there is a dearth of information on whether reinfections differ from the initial infection in their incidence, severity, and attributes, as well as on the long COVID complications after SARS-CoV-2 reinfections.

About the study

In the present study, the team used electronic health record data of a cohort exceeding 1.5 million individuals involved in the National COVID Cohort Collaborative (N3C), which is a part of the National Institute of Health’s Researching COVID to Enhance Recovery (RECOVER) initiative. This data was used to evaluate the incidence, biomarkers, and attributes of SARS-CoV-2 reinfections and understand the association between post-acute sequelae of SARS-CoV-2 infection (PASC) and reinfections.

Reinfection was defined based on a positive SARS-CoV-2 antigen or polymerase chain reaction (PCR) test more than 60 days after the index date for the initial SARS-CoV-2 infection. Long COVID was defined based on the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes.

Reinfections were also examined according to the epochs of SARS-CoV-2 variants, with the epoch of the wild-type strain spanning the March to November 2020 period, the Alpha, Beta, and Gamma variants dominating the December 2020–May 2021 period, and the Delta variant epoch spanning the June 2021–October 2022 period. The Omicron epoch was divided into two parts for the Omicron variant and the Omicron BA variants, corresponding to November 2021–March 2022 and March–August 2022, respectively.

Biomarkers such as inflammation, coagulopathies, and organ dysfunction can be used to characterize SARS-CoV-2 infections. A wide range of biomarkers, including laboratory measurements of white blood cell counts, erythrocyte sedimentation rates, C-reactive protein, serum creatinine, albumin, and many more, were used to characterize reinfections.

COVID-associated hospitalization data was used to determine the severity of reinfections. Mild infections included those that did not require a visit to the emergency department or hospitalization, while those requiring hospitalization were categorized as moderately severe, and cases requiring hospitalization, invasive mechanical ventilators, vasopressors, or extracorporeal membrane oxygenation were considered severe infections.

The period between reinfection and long COVID diagnoses was compared with that between the initial infection and diagnosis of long COVID to understand the relationship between reinfections and PASC.

Results

The results indicated that most individuals in the cohort had one reinfection, with a small group comprising largely of non-Hispanic White males and older individuals having had three or more reinfections. The largest number of reinfections during the Omicron epoch were among individuals who had initial SARS-CoV-2 infections during the epochs of the wild-type, Alpha, Beta, and Gamma strains, followed by reinfections among those with initial Delta infections.

Analyses of biomarkers revealed that compared to the initial SARS-CoV-2 infection, reinfections showed lower elevation of hepatic inflammation markers such as alanine transaminase (ALT) and aspartate transaminase (AST). However, albumin levels were consistently low in reinfection patients.

Furthermore, the severity of reinfections was found to be associated with the severity of the initial SARS-CoV-2 infections. A majority of the cohort experienced mild symptoms during the initial infections and reinfections and did not require hospitalization or a visit to the emergency department. Compared to the initial infection, the percentage of individuals who required hospitalization or succumbed to the infection after reinfection was marginally lower (14.4% vs. 12.6%). Close to half the patients who experienced a severe initial SARS-CoV-2 infection had moderate symptoms requiring hospitalization or emergency department visits during reinfection. Additionally, 7.4% of the individuals who had a severe initial infection had severe infections, and 5.7% succumbed to the reinfection.

Long COVID diagnoses also occurred in a shorter time frame for infections or reinfections during the Omicron epoch, as compared to infections during the Delta epoch or those with other variants.

Conclusions

Overall, the results indicated that the severity of SARS-CoV-2 reinfections was similar to those of the initial infection, with individuals who experienced mild to moderate symptoms during the first infection having similar symptoms during reinfection, while individuals who experienced a severe initial infection having similar reinfection symptoms or succumbing to the disease after reinfection.

Additionally, the study reported that long COVID diagnoses during the Omicron epoch occurred much closer to the index date of the infection or reinfection, and the number of long COVID diagnoses also showed an increase after reinfections with recent variants.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:

  • Emily Hadley, Yun Jae Yoo, Saaya Patel, Andrea Zhou, Bryan Laraway, Rachel Wong, Alexander Preiss, Rob Chew, Hannah Davis, Christopher G Chute, Emily R Pfaff, Johanna Loomba, Melissa Haendel, Elaine Hill, Richard Moffitt. (2023). SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study:  and the N3C and RECOVER consortia. medRxiv. doi: https://doi.org/10.1101/2023.01.03.22284042 https://www.medrxiv.org/content/10.1101/2023.01.03.22284042v1

Read original article here

China state media plays down COVID wave severity before WHO meet

  • State media says severe illness from COVID is rare
  • Chinese scientists expected to brief WHO
  • China factory activity shrinks in December

BEIJING, Jan 3 (Reuters) – China’s state media played down the severity on Tuesday of the COVID-19 wave surging over the country, with its scientists expected to give a briefing to the World Health Organization on the evolution of the virus later in the day.

China’s abrupt U-turn on COVID controls on Dec. 7, as well as the accuracy of its case and mortality data, have come under increasing scrutiny at home and overseas and prompted some countries to impose travel curbs.

The policy shift followed protests over the “zero COVID” approach championed by President Xi Jinping, marking the strongest show of public defiance in his decade-old presidency and coinciding with the slowest growth in China in nearly half a century.

As the virus spreads unchecked, funeral parlours report a spike in demand for their services and international health experts predict at least one million deaths in the world’s most populous country this year.

China reported three new COVID deaths for Monday, up from one for Sunday. Its official death toll since the pandemic began now stands at 5,253.

In an article on Tuesday, People’s Daily, the official newspaper of the Communist Party, cited several Chinese experts as saying the illness caused by the virus was relatively mild for most people.

“Severe and critical illnesses account for 3% to 4% of infected patients currently admitted to designated hospitals in Beijing,” Tong Zhaohui, Vice President of Beijing Chaoyang Hospital, told the newspaper.

Kang Yan, head of West China Tianfu Hospital of Sichuan University, said that in the past three weeks, a total of 46 critically ill patients have been admitted to intensive care units, accounting for about 1% of symptomatic infections.

More than 80% of those living in the southwestern Sichuan province have been infected, local health authorities said.

The World Health Organization on Friday urged China’s health officials to regularly share specific and real-time information on the COVID situation.

The agency has invited Chinese scientists to present detailed data on viral sequencing at a meeting of a technical advisory group scheduled for Tuesday. It has also asked China to share data on hospitalizations, deaths and vaccinations.

The European Union has offered free COVID vaccines to China to help contain the outbreak, the Financial Times reported on Tuesday.

EU government health officials will hold talks on Wednesday on a coordinated response to China’s outbreak, the Swedish EU presidency said on Monday.

The United States, France, Australia, India and others will require mandatory COVID tests on travellers from China, while Belgium said it will test wastewater from planes from China for new COVID variants.

China has rejected criticism of its COVID data and said any new mutations may be more infectious but less harmful.

“According to the political logic of some people in Europe and the United States, whether China opens or does not open is equally the wrong thing to do,” state-run CCTV said in a commentary late on Monday.

ECONOMIC CONCERNS

As Chinese workers and shoppers are falling ill, concerns mount about growth prospects in the world’s second-largest economy, weighing on Asian stocks.

Data on Tuesday showed China’s factory activity shrank at a sharper pace in December as the COVID wave disrupted production and hurt demand.

December shipments from Foxconn’s (2317.TW) Zhengzhou iPhone plant, disrupted late last year by a COVID outbreak that prompted worker departures and unrest, were 90% of the firm’s initial plans, a source with direct knowledge of the matter said.

A “bushfire” of infections in China in coming months is likely to hurt its economy this year and drag on global growth, said the head of the International Monetary Fund, Kristalina Georgieva.

“China is entering the most dangerous weeks of the pandemic,” warned analysts at Capital Economics.

“The authorities are making almost no efforts now to slow the spread of infections and, with the migration ahead of Lunar New Year getting started, any parts of the country not currently in a major COVID wave will be soon.”

Mobility data suggested that economic activity was depressed nationwide and would likely remain so until the infection wave began to subside, they added.

China’s Ministry of Culture and Tourism said the domestic tourism market saw 52.71 million trips during the New Year holiday, flat year-on-year and only 43% of the 2019 levels, before the pandemic.

The revenue generated was over 26.52 billion yuan ($3.84 billion), up 4% year-on-year but only about 35% of the revenue created in 2019, the ministry said.

Expectations are higher for China’s biggest holiday, the Lunar New Year, later this month, when some experts expect daily COVID cases to have already peaked in many parts of the country. Some hotels in the southern tourist resort of Sanya are fully booked for the period, Chinese media reported.

Reporting by Beijing and Shanghai bureaus; Writing by Marius Zaharia; Editing by Raju Gopalakrishnan

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

China softens tone on COVID severity after protests

BEIJING, Dec 1 (Reuters) – China is softening its tone on the severity of COVID-19 and easing some coronavirus restrictions even as its daily case toll hovers near record highs, after anger over the world’s toughest curbs fuelled protests across the country.

Several cities in the world’s second-largest economy, while still reporting new infections, are breaking with practice by lifting district lockdowns and allowing businesses to reopen.

Health authorities announcing the relaxation of measures did not mention the protests, which ranged from candle-lit vigils in Beijing to clashes with the police on the streets of Guangzhou on Tuesday and at an iPhone factory in Zhengzhou last week.

The demonstrations marked the biggest show of civil disobedience in mainland China since President Xi Jinping took power a decade ago and come as the economy is set to enter a new era of much slower growth than seen in decades.

Despite near-record case numbers, Vice Premier Sun Chunlan, who oversees COVID efforts, said the virus’s ability to cause disease was weakening, state media reported.

“The country is facing a new situation and new tasks in epidemic prevention and control as the pathogenicity of the Omicron virus weakens, more people are vaccinated and experience in containing the virus is accumulated,” Sun said in comments reported in state media.

Sun also urged further “optimisation” of testing, treatment and quarantine policies.

The mention of a weakening pathogenicity contrasts with earlier messages from authorities about the deadliness of the virus.

CHANGING RULES

Less than 24 hours after violent protests in Guangzhou, authorities in at least seven districts of the sprawling manufacturing hub north of Hong Kong, said they were lifting temporary lockdowns. One district said it would allow in-person classes in schools to resume and would reopen restaurants and other businesses including cinemas.

Some changes are being implemented with little fanfare.

A community of thousands in east Beijing is allowing infected people with mild symptoms to isolate at home, according to new rules issued by the neighbourhood committee and seen by Reuters.

Neighbours on the same floor and three stories above and below the home of a positive case should also quarantine at home, a committee member said.

That is a far cry from quarantine protocols earlier in the year when entire communities were locked down, sometimes for weeks, after even just one positive case was found.

Another community nearby is holding an online poll this week on the possibility of positive cases isolating at home, residents said.

“I certainly welcome the decision by our residential community to run this vote regardless of the outcome,” said resident Tom Simpson, managing director for China at the China-Britain Business Council.

He said his main concern was being forced to go into a quarantine facility, where “conditions can be grim to say the least”.

Prominent nationalist commentator Hu Xijin said in a social media post on Wednesday that many asymptomatic carriers of coronavirus in Beijing were already quarantining at home.

The southwestern city of Chongqing will allow close contacts of people with COVID, who meet certain conditions, to quarantine at home, while Zhengzhou in central China announced the “orderly” resumption of businesses, including supermarkets, gyms and restaurants.

National health officials said this week authorities would respond to “urgent concerns” raised by the public and that COVID rules should be implemented more flexibly, according to a region’s conditions.

RE-OPENING NEXT YEAR?

Expectations have grown around the world that China, while still trying to contain infections, could look to re-open at some point next year once it achieves better vaccination rates among its elderly.

Health experts warn of widespread illness and death if COVID is let loose before vaccination is ramped up.

Chinese stocks and markets around the world dipped initially after the weekend protests in Shanghai, Beijing and other cities, but later recovered on hopes that public pressure could lead to a new approach by authorities.

More COVID outbreaks could weigh on China’s economic activity in the near term, the International Monetary Fund said on Wednesday, adding it saw scope for a safe recalibration of policies that could allow economic growth to pick up in 2023.

China’s strict containment measures have dampened domestic economic activity this year and spilled over to other countries through supply chain interruptions.

Following downbeat data in an official survey on Wednesday, the Caixin/S&P Global manufacturing purchasing managers’ index showed factory activity shrank in November for a fourth consecutive month. read more

While the change in tone on COVID appears a response to the public discontent with strict measures, authorities are also seeking out for questioning those present at the demonstrations.

China Dissent Monitor, run by U.S. government-funded Freedom House, estimated at least 27 demonstrations took place across China from Saturday to Monday. Australia’s ASPI think tank estimated 43 protests in 22 cities.

Additional reporting by Ellen Zhang; Writing by Marius Zaharia; Editing by Michael Perry, Robert Birsel

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

Flu season 2022 started a month early, severity is highest in 13 years

Comment

Influenza is hitting the United States unusually early and hard, already hospitalizing a record number of people at this point in the season in more than a decade and underscoring the potential for a perilous winter of respiratory viruses, according to federal health data released Friday.

While flu season is usually between October and May, peaking in December and January, it’s arrived about six weeks earlier this year with uncharacteristically high illness. There have already been at least 880,000 cases of influenza illness, 6,900 hospitalizations and 360 flu-related deaths nationally, including one child, according to estimates released Friday by the Centers for Disease Control and Prevention.

Not since the 2009 H1N1 swine flu pandemic has there been such a high burden of flu, a metric the CDC uses to estimate a season’s severity based on laboratory-confirmed cases, doctor visits, hospitalizations and deaths.

“It’s unusual, but we’re coming out of an unusual covid pandemic that has really affected influenza and other respiratory viruses that are circulating,” said Lynnette Brammer, an epidemiologist who heads the CDC’s domestic influenza surveillance team.

Activity is high in the U.S. south and southeast, and is starting to move up the Atlantic coast.

The CDC uses a variety of measures to track flu, including estimating the percentage of doctor visits for flu-like illness. But given the similar symptoms that could include people seeking care for covid-19 or RSV, another respiratory virus with similar symptoms, the laboratory data leaves no doubt.

“The data are ominous,” said William Schaffner, medical director for the nonprofit National Foundation for Infectious Diseases and a professor of infectious diseases at that Vanderbilt University School of Medicine. “Not only is flu early, it also looks very severe. This is not just a preview of coming attractions. We’re already starting to see this movie. I would call it a scary movie.”

Adding to his concern, he said, is that influenza vaccine acceptance is lagging behind where it usually is at this point in the season. “That makes me doubly worried,” he said. The high burden of flu “certainly looks like the start of what could be the worst flu season in 13 years.”

The number of flu cases this season is already one-eighth of last season’s total estimate of 8 to 13 million cases.

So far, flu vaccination rates in the United States are lower than they have been at this point in the season in the past few years. About 128 million doses of flu vaccine have been distributed so far, compared with 139 million at this point last year and 154 million the year before, according to the CDC.

The latest flu data comes as the nation’s strained public health system is grappling with multiple virus threats. Coronavirus cases are expected to increase as the country heads into colder weather and more people gather indoors. Children’s hospitals are filling up with a record number of kids infected with RSV.

The flu vaccine’s effectiveness in preventing a doctor’s visit, hospitalization or death is uneven from year to year, and in years past, has hovered between 40 and 60 percent, according to the CDC. But Brammer and others say this season’s vaccine is well matched against circulating strains. That offers a “little ray of sunshine” for what could be a bleak winter, Schaffner said.

Nationally, the predominant virus — a particularly nasty strain, H3N2 — causes the worst outbreaks of the two types of influenza A viruses and two influenza B viruses that circulate among people. Seasons where H3N2 dominate typically result in the most complications, especially for the very young, the elderly and people with certain chronic health conditions, experts say.

What many people don’t realize is that even after someone recovers from flu, the inflammatory response generated by the virus continues to wreak havoc for another four to six weeks in those who are middle-aged and older, increasing the rate of heart attacks and strokes, Schaffner said.

Influenza has not been a serious problem the last two years, experts and health officials have said, because of the masking, social distancing and other measures people took to protect themselves against covid-19.

Health officials tend to consider a flu season to be officially underway after consecutive weeks of flu activity from several surveillance systems, including a significant percentage of doctor’s office visits for flu-like illnesses. Those doctor visits have increased for three weeks in a row as of Oct. 22, more than a month earlier than previous seasons, the CDC’s Brammer said.

Flu is famously difficult to predict. It’s hard to know how long the season will last, how severe it might be, and if different parts of the country will experience different levels of respiratory disease at different times. Last season, flu activity peaked in January, “then dropped like a stone, then smoldered just under the epidemic threshold beyond March into April, May and June,” said Schaffner. That “long smoldering tail was very unusual.”

“An early start doesn’t always mean severe,” Brammer said.

In the southern hemisphere, influenza season has also been far different, Brammer said. In Australia, there was a “really sharp, very fast uptake then very quick drop,” she said. In Argentina, the peak flu activity occurred at what would have been that country’s summer.

“Things have not settled back into a normal pattern,” Brammer said.

Chile got ahead of its bad flu season, which began months earlier than a typical season, by rapidly vaccinating 88 percent of its high-risk population before peak influenza activity, according to a CDC report this week. The flu vaccine used in Chile, which included a match for the dominant H3N2 virus, was about 50 percent effective in preventing hospitalization. The shot used in the Northern Hemisphere includes the same virus makeup as the Southern Hemisphere vaccine, so experts hope the formulation might be similarly effective in preventing severe influenza illnesses.

The latest CDC data show overall respiratory illness activity is “very high” in South Carolina and Washington, D.C. and “high” in 11 states: Alabama, Georgia, Louisiana, Maryland, Mississippi, New Jersey, New York City, North Carolina, Tennessee, Texas and Virginia.

Texas was among the earliest states to see flu activity in late September. At the Houston Methodist hospital system, laboratory-confirmed influenza cases have risen to 975 as of Oct. 20, up from 561 the week before, officials said.

Officials had been bracing for a more robust flu season this fall and winter because so many people have dropped covid protection measures and are reluctant to get vaccinated.

“This was something that we were expecting because we are a hub, and a lot of people are traveling here,” said Cesar Arias, the hospital system’s chief of infectious diseases. “I didn’t expect to see that much [flu] that early.”

Arias said conversations around flu vaccinations have become tied to the hesitancy around coronavirus vaccines. The conversations in Texas, “as you can imagine, [are] stronger and at least more vocal,” he said. “We are struggling with that, trying to put the message out to get vaccinated.”

People need to get a new flu vaccine every year to be protected, and it takes up to two weeks for protection to kick in and for the vaccine to work. Flu is contagious before symptoms start. CDC recommends that everyone ages 6 months and older get a flu vaccine, ideally by the end of October.

Read original article here

VMware bug with 9.8 severity rating exploited to install witch’s brew of malware

Hackers have been exploiting a now-patched vulnerability in VMware Workspace ONE Access in campaigns to install various ransomware and cryptocurrency miners, a researcher at security firm Fortinet said on Thursday.

CVE-2022-22954 is a remote code execution vulnerability in VMware Workspace ONE Access that carries a severity rating of 9.8 out of a possible 10. VMware disclosed and patched the vulnerability on April 6. Within 48 hours, hackers reverse-engineered the update and developed a working exploit that they then used to compromise servers that had yet to install the fix. VMware Workspace ONE access ​​helps administrators configure a suite of apps employees need in their work environments.

In August, researchers at Fortiguard Labs saw a sudden spike in exploit attempts and a major shift in tactics. Whereas before the hackers installed payloads that harvested passwords and collected other data, the new surge brought something else—specifically, ransomware known as RAR1ransom, a cryptocurrency miner known as GuardMiner, and Mirai, software that corrals Linux devices into a massive botnet for use in distributed denial-of-service attacks.

FortiGuard

“Although the critical vulnerability CVE-2022-22954 is already patched in April, there are still multiple malware campaigns trying to exploit it,” Fortiguard Labs researcher Cara Lin wrote. Attackers, she added, were using it to inject a payload and achieve remote code execution on servers running the product.

The Mirai sample Lin saw getting installed was downloaded from http[:]//107[.]189[.]8[.]21/pedalcheta/cutie[.]x86_64 and relied on a command and control server at “cnc[.]goodpackets[.]cc. Besides delivering junk traffic used in DDoSes, the sample also attempted to infect other devices by guessing the administrative password they used. After decoding strings in the code, Lin found the following list of credentials the malware used:

hikvision

1234

win1dows

S2fGqNFs

root

tsgoingon

newsheen

12345

default

solokey

neworange88888888

guest

bin

user

neworang

system

059AnkJ

telnetadmin

tlJwpbo6

iwkb

141388

123456

20150602

00000000

adaptec

20080826

vstarcam2015

v2mprt

Administrator

1001chin

vhd1206

support

NULL

xc3511

QwestM0dem

7ujMko0admin

bbsd-client

vizxv

fidel123

dvr2580222

par0t

hg2x0

samsung

t0talc0ntr0l4!

cablecom

hunt5759

epicrouter

zlxx

pointofsale

nflection

admin@mimifi

xmhdipc

icatch99

password

daemon

netopia

3com

DOCSIS_APP

hagpolm1

klv123

OxhlwSG8

In what appears to be a separate campaign, attackers also exploited CVE-2022-22954 to download a payload from 67[.]205[.]145[.]142. The payload included seven files:

  • phpupdate.exe: Xmrig Monero mining software
  • config.json: Configuration file for mining pools
  • networkmanager.exe: Executable used to scan and spread infection
  • phpguard.exe: Executable used for guardian Xmrig miner to keep running
  • init.ps1: Script file itself to sustain persistence via creating scheduled task
  • clean.bat: Script file to remove other cryptominers on the compromised host
  • encrypt.exe: RAR1 ransomware

In the event RAR1ransom has never been installed before, the payload would first run the encrypt.exe executable file. The file drops the legitimate WinRAR data compression executable in a temporary Windows folder. The ransomware then uses WinRAR to compress user data into password-protected files.

The payload would then start the GuardMiner attack. GuardMiner is a cross-platform mining Trojan for the Monero currency. It has been active since 2020.

The attacks underscore the importance of installing security updates in a timely manner. Anyone who has yet to install VMware’s April 6 patch should do so at once.

Read original article here

Retinal Test a New Prognostic Marker for Multiple Sclerosis Severity

Summary: Multiple sclerosis-associated retinal layer thinning predicts the severity of future relapses and the likelihood of disability.

Source: Medical University of Vienna

It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods.

A MedUni Vienna study now shows for the first time that the retina can be used as a prognostic marker.

Analyses revealed that retinal layer thinning as a result of an MS relapse predicts the severity of future relapses and, hence, the likelihood of disability.

The results of the study have now been published in Neurology.

Researchers led by Gabriel Bsteh and Thomas Berger from the Department of Neurology at MedUni Vienna/University Hospital Vienna, working in collaboration with the Department of Ophthalmology and Optometrics at MedUni Vienna/University Hospital Vienna, studied 167 MS patients over a period of more than three years.

They hypothesized that retinal damage due to relapse reflects the extent of damage in the brain. As the scientific analyses confirmed, the loss of approximately 5 µm (micrometers) of retinal layer thickness after optic neuritis equates to a doubling of the risk of permanent disability after the next relapse.

These predictions could be used as the basis for treatment decisions in future: the results of the study suggest that more aggressive treatment is indicated where there is significant retinal layer thinning than would be the case for a smaller degree of thinning. This is true even if the patient has no disability or only slight disability at the time of measurement.

Prognostic technique already available

The researchers used optical coherence tomography (OCT) to measure retinal layer thickness. OCT is an imaging technique that uses infrared light to produce high-resolution three-dimensional images of very thin layers of tissue in the micrometer range (1 micrometer=1 thousandth of a millimeter). It is already used as a tool for diagnosing eye diseases such as glaucoma, and for evaluating disease progression.

Analyses revealed that retinal layer thinning as a result of an MS relapse predicts the severity of future relapses and, hence, the likelihood of disability. Image is in the public domain

“The technique for predicting the course of MS is therefore already available to us,” said Gabriel Bsteh, first author of the study. “As we discovered in the course of our clinical trial, measurements should be taken at initial diagnosis, directly when optic neuritis occurs in relapsing MS, and six months thereafter.”

See also

The retina as a window to the brain

Multiple sclerosis is a chronic inflammatory autoimmune disease that leads to the loss of axons and neurons throughout the entire nervous system. Although this damage often goes unnoticed by patients at first, its extent determines the prognosis for the severity of the disease.

Since predictions about the course of the disease are important in MS for selecting the appropriate treatment, medical research has long been searching for reliable prognostic tools.

“In retinal layer thickness, we have found a new biomarker that represents a window to the brain, as it were,” said Gabriel Bsteh, summarizing the essence of the study. If the results are confirmed in larger follow-up studies, the technique could also be applied in routine clinical practice.

About this multiple sclerosis research news

Author: Press Office
Source: Medical University of Vienna
Contact: Press Office – Medical University of Vienna
Image: The image is in the public domain

Original Research: The findings will appear in Neurology

Read original article here

Video: Boston doctor describes severity of pediatric hepatitis cases

>

Video: Boston doctor describes severity of pediatric hepatitis cases – YouTubeInfoPresseUrheberrechtKontaktCreatorWerbenEntwicklerImpressumNetzDG TransparenzberichtNetzDG-BeschwerdenNutzungsbedingungenDatenschutzRichtlinien & SicherheitWie funktioniert YouTube?Neue Funktionen testen

Read original article here

The Ultimate News Site